First "chemofog" syndrome reported for cancer anti-angiogenic targeted therapy in a preclinical model - Normandie Université Access content directly
Conference Papers Year : 2014
No file

Dates and versions

hal-02299483 , version 1 (27-09-2019)

Identifiers

  • HAL Id : hal-02299483 , version 1

Cite

Martine Dubois, Benjamin Quignon, Marie-Christine Tonon, Pierrick Gandolfo, Florence Joly, et al.. First "chemofog" syndrome reported for cancer anti-angiogenic targeted therapy in a preclinical model. World Congress on Neurotherapeutics (DDDN), Sep 2014, Bâle, Switzerland. ⟨hal-02299483⟩
27 View
0 Download

Share

Gmail Mastodon Facebook X LinkedIn More